[HTML][HTML] Patterns of cannabis and alcohol co-use: Substitution versus complementary effects

RL Gunn, ER Aston, J Metrik - Alcohol Research: Current Reviews, 2022 - ncbi.nlm.nih.gov
PURPOSE The purpose of this review is to discuss the literature regarding the concurrent
use (co-use) of alcohol and cannabis and competing hypotheses as to whether cannabis …

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

LA Ray, S Bujarski, E Grodin, E Hartwell… - The American journal …, 2019 - Taylor & Francis
Background: Alcohol use disorder (AUD) and its associated consequences remain
significant public health concerns. Given that AUD represents a spectrum of severity …

Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies

M Farokhnia, CT Rentsch, V Chuong, MA McGinn… - Molecular …, 2022 - nature.com
Evidence suggests that spironolactone, a nonselective mineralocorticoid receptor (MR)
antagonist, modulates alcohol seeking and consumption. Therefore, spironolactone may …

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

EN Grodin, S Bujarski, B Towns, E Burnette… - Translational …, 2021 - nature.com
Ibudilast, a neuroimmune modulator which selectively inhibits phosphodiesterases (PDE)-3,-
4,-10, and-11, and macrophage migration inhibitory factor (MIF), shows promise as a novel …

Translational opportunities in animal and human models to study alcohol use disorder

SJ Nieto, EN Grodin, CG Aguirre, A Izquierdo… - Translational …, 2021 - nature.com
Animal and human laboratory paradigms offer invaluable approaches to study the complex
etiologies and mechanisms of alcohol use disorder (AUD). We contend that human …

Evidence for incentive salience sensitization as a pathway to alcohol use disorder

RU Cofresí, BD Bartholow, TM Piasecki - Neuroscience & Biobehavioral …, 2019 - Elsevier
The incentive salience sensitization (ISS) theory of addiction holds that addictive behavior
stems from the ability of drugs to progressively sensitize the brain circuitry that mediates …

Understanding low treatment seeking rates for alcohol use disorder: a narrative review of the literature and opportunities for improvement

A Venegas, S Donato, LR Meredith… - The American journal of …, 2021 - Taylor & Francis
Despite a well-documented global burden of disease attributable to alcohol use disorder
(AUD), treatment seeking rates remain low. In this qualitative literature review, we address …

Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation

P Sampedro-Piquero, DL de Guevara-Miranda… - Neuroscience & …, 2019 - Elsevier
Drug addiction is a chronic and relapsing disorder in which repeated drug exposure
compromises brain neuroplasticity. Brain areas normally involved in learning and goal …

The Addictions Neuroclinical Assessment negative emotionality domain among treatment‐seekers with alcohol use disorder: Construct validity and measurement …

VR Votaw, MR Pearson, E Stein… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background The Addictions Neuroclinical Assessment (ANA), a framework for measuring
heterogeneity in alcohol use disorder (AUD), focuses on 3 domains that reflect …

Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder

EM Burnette, LA Ray, MR Irwin… - Alcoholism: Clinical and …, 2021 - Wiley Online Library
Background Ibudilast, a novel neuroimmune modulator being studied to treat alcohol use
disorder (AUD), was shown in a randomized controlled trial (NCT03489850) to reduce …